Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

2-tert-butoxycarbonylamino-3-(4-(2-(2-hydroxyethyl)-5-methoxy-3-oxo-2,3-dihydropyridazin-4-yl)phenyl)propionic acid 2-hydroxyethyl ester MeSH Supplementary Concept Data 2025


MeSH Supplementary
2-tert-butoxycarbonylamino-3-(4-(2-(2-hydroxyethyl)-5-methoxy-3-oxo-2,3-dihydropyridazin-4-yl)phenyl)propionic acid 2-hydroxyethyl ester
Unique ID
C511641
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C511641
Entry Term(s)
BHPA 2-hydroxyethyl ester
Registry Numbers
0
Heading Mapped to
Phenylalanine / analogs & derivatives
*Pyridazines
Frequency
1
Note
an alpha4 integrin receptor antagonist; structure in first source
Source
J Med Chem 2006 Jun 1;49(11):3402-11
Date of Entry
2006/07/09
Revision Date
2006/07/09
2-tert-butoxycarbonylamino-3-(4-(2-(2-hydroxyethyl)-5-methoxy-3-oxo-2,3-dihydropyridazin-4-yl)phenyl)propionic acid 2-hydroxyethyl ester Preferred
page delivered in 0.007s